137 results
8-K
EX-99.1
ACGN
Aceragen Inc
4 Mar 08
Results of Operations and Financial Condition
12:00am
. collaboration, which costs are reimbursed by Merck & Co., and compensation costs associated with hiring additional personnel to support the Company’s … with hiring contract personnel to support the Company’s drug development efforts and stock-based compensation. The 2007 increase was offset, in part
8-K
EX-99.1
ACGN
Aceragen Inc
1 Dec 14
Idera Pharmaceuticals Names Vincent J. Milano Chief Executive Officer
12:00am
5635(c)(4)
In connection with the hiring of Mr. Milano, the Board of Directors of the Company approved the grant to Mr. Milano of a stock option
8-K
y2m5x0lg7 6j7q2rm5
15 Apr 04
Other events
12:00am